10 Aussie stocks to buy in FY 2026

Let's see which shares analysts think could be buys in the upcoming financial year.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With the new financial year upon us, investors may be wondering where to find the best opportunities on the ASX.

Let's take a look at 10 Aussie stocks that analysts are positive on as we head into FY 2026. They are as follows:

A happy young couple lie on a wooden deck using a skateboard for a pillow.

Image source: Getty Images

Aristocrat Leisure Ltd (ASX: ALL)

This gaming and technology powerhouse has impressed over the past decade with strong and consistent growth. And with its sizeable investment in research and development and content, it appears well-placed to build on this in FY 2026 and beyond.

Bell Potter is a fan and recently put a buy rating and $79.00 price target on this Aussie stock.

Aurizon Holdings Ltd (ASX: AZJ)

Rail freight operator Aurizon offers exposure to the nation's transport and logistics sector with a focus on coal, agriculture, and industrial freight. It is also a dividend payer with a big forecast yield which could appeal to income-focused investors.

Last week, Macquarie upgraded its shares to an outperform rating with a $3.39 price target.

Cochlear Ltd (ASX: COH)

Another Aussie stock to look at is Cochlear. It is a leader in hearing implant technology and has strong tailwinds from ageing global populations. Recent product launches and its R&D investment look set to cement its leadership position for a long time to come.

Analysts at UBS have a buy rating and $325.00 price target on its shares.

CSL Ltd (ASX: CSL)

CSL is one of Australia's crown jewels in healthcare. With a world-class plasma therapy business and expanding vaccine and biotech capabilities, it is well-positioned to grow in FY 2026 and beyond. In fact, double-digit earnings growth is forecast by many analysts over the remainder of 2020s.

Bell Potter is bullish on CSL and has a buy rating and $305.00 price target on its shares.

Goodman Group (ASX: GMG)

As one of the world's largest industrial property companies, Goodman is tapping into strong demand for logistics and data centre infrastructure. Its global footprint and world class pipeline of projects make it a standout in the property sector.

Citi has a buy rating and $40.00 price target on its shares.

Megaport Ltd (ASX: MP1)

This network-as-a-service provider looks well-positioned for growth over the long term. This is thanks to its exposure to cloud computing and artificial intelligence trends. Morgans thinks it is "is uniquely placed to help business move data globally and benefit from the growth of data related to both cloud computing and AI."

The broker has an accumulate rating and $15.50 price target on Megaport's shares.

NextDC Ltd (ASX: NXT)

Another Aussie stock benefit from the AI boom is NextDC. As one of the Asia-Pacific's leading data centre operators, it is capitalising on the massive demand for data storage and connectivity. In fact, the company recently revealed a record pro forma forward order book of 135MW. This compares to its total contracted utilisation of 176MW during the first half.

The team at Macquarie has an outperform rating and $22.10 price target on its shares.

Pilbara Minerals Ltd (ASX: PLS)

Lithium prices may have cooled off, but Pilbara Minerals is still profitable thanks to its quality assets and low costs. If sentiment turns and demand accelerates, it could be well placed to ride the next wave of the energy transition.

Macquarie is bullish on the lithium miner and has an outperform rating and $2.40 price target on its shares.

ResMed Inc. (ASX: RMD)

ResMed continues to benefit from long-term demand for sleep apnoea treatment and respiratory care. And with an estimated addressable market of over 1 billion people, it has decades of growth ahead of it.

Macquarie has an outperform rating and $48.00 price target on ResMed's shares.

Temple & Webster Group Ltd (ASX: TPW)

Temple & Webster is the leader in online furniture and homewares. While consumer sentiment may remain soft in the near term, the structural shift online and its strong brand leave this Aussie stock well-positioned for growth in FY 2026 and beyond.

Morgan Stanley is bullish on its outlook. It has an overweight rating and $28.00 price target on its shares.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in CSL, Cochlear, Goodman Group, Megaport, Nextdc, ResMed, and Temple & Webster Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Cochlear, Goodman Group, Macquarie Group, Megaport, ResMed, and Temple & Webster Group. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended CSL, Cochlear, Goodman Group, and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »